West Pharmaceutical Services | WST - Selling And Administration Expenses

Stock Price
237.43
Daily Change
6.31 2.73%
Monthly
-14.91%
Yearly
-29.55%
Q1 Forecast
224.00

West Pharmaceutical Services reported $102.7M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Align Technology USD 417.8M 30.89M Sep/2025
Avanos Medical USD 77.6M 5.9M Sep/2025
Baxter International USD 708M 10M Sep/2025
Becton, Dickinson and Co. USD 1.37B 46M Sep/2025
Charles River Laboratories USD 177.59M 8.23M Sep/2025
Cooper Companies USD 419.2M 12M Sep/2025
Dentsply International USD 355M 21M Sep/2025
Haemonetics USD 101.62M 10.37M Sep/2025
ICU Medical USD 152.77M 6.62M Sep/2025
Insulet USD 315.2M 61.9M Sep/2025
Integra LifeSciences USD 169.05M 10.84M Sep/2025
IQVIA Holdings USD 514M 5M Sep/2025
J&J USD 6.75B 831M Dec/2025
Medtronic 2.97B 159M Sep/2025
Merit Medical Systems USD 107.38M 5.72M Sep/2025
Neogen USD 107.5M 1.56M Sep/2025
Quidel USD 186.9M 16.8M Sep/2025
Repligen USD 73.66M 2.43M Sep/2025
Solventum Corp USD 744M 28M Sep/2025
STAAR Surgical USD 59.38M 18.08M Sep/2025
Terumo JPY 97.88B 5.9B Sep/2025
West Pharmaceutical Services USD 102.7M 6.8M Sep/2025